CMH :: Clinical and Molecular Hepatology

Clinical and Molecular Hepatology Search

> Browse Articles > Search

Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis

Keiji Yokoyama, Ryo Yamauchi, Kumiko Shibata, Hiromi Fukuda, Hideo Kunimoto, Kazuhide Takata, Takashi Tanaka, Shinjiro Inomata, Daisuke Morihara, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka

Clin Mol Hepatol.2019;25(2):183-189. Published online November 9, 2018
DOI: https://doi.org/10.3350/cmh.2018.0039

Cited By 1

Role of endoscopic treatment or balloon-occluded retrograde transvenous obliteration in patients with Child-Pugh class C end-stage liver cirrhosis and esophageal/gastric varices

Jin Wook Chung

Clin Mol Hepatol.2019;25(2):181-182. Published online December 21, 2018
DOI: https://doi.org/10.3350/cmh.2018.1010

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients

Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht

Clin Mol Hepatol.2019;25(1):42-51. Published online November 19, 2018
DOI: https://doi.org/10.3350/cmh.2018.0029

Cited By 1

Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis

Soon Kyu Lee, Myeong Jun Song, Seok Hwan Kim, Hyo Jun Ahn

Clin Mol Hepatol.2018;24(4):409-416. Published online August 27, 2018
DOI: https://doi.org/10.3350/cmh.2018.0034

Cited By 2

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL

Jong Eun Yeon

Clin Mol Hepatol.2018;24(3):278-293. Published online May 2, 2018
DOI: https://doi.org/10.3350/cmh.2018.1002

Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis

Wataru Ando, Hiroaki Yokomori, Nobuhiro Tsutsui, Eigoro Yamanouchi, Yutaka Suzuki, Masaya Oda, Yutaka Inagaki, Katsuya Otori, Isao Okazaki

Clin Mol Hepatol.2018;24(1):61-76. Published online November 20, 2017
DOI: https://doi.org/10.3350/cmh.2017.0030

Cited By 2

Life-sustaining treatment and palliative care in patients with liver cirrhosis - legal, ethical, and practical issues

Dong Joon Kim, Moon Seok Choi

Clin Mol Hepatol.2017;23(2):115-122. Published online May 2, 2017
DOI: https://doi.org/10.3350/cmh.2017.0018

Cited By 5

Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis

Gaeun Kim, Moon Young Kim, Soon Koo Baik

Clin Mol Hepatol.2017;23(1):34-41. Published online March 7, 2017
DOI: https://doi.org/10.3350/cmh.2016.0059

Cited By 20

Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban

Hyeyoung Yang, Seo Ree Kim, Myeong Jun Song

Clin Mol Hepatol.2016;22(4):499-502. Published online November 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0016

Cited By 9

Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach

Sang Jung Park, Yong Kwon Kim, Yeon Seok Seo, Seung Woon Park, Han Ah Lee, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jae Young Jang, Jong Eun Yeon, Kwan Soo Byun

Clin Mol Hepatol.2016;22(4):487-494. Published online December 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0050

Cited By 4

Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding

Su Jin Kim, Cheol Woong Choi, Dae Hwan Kang, Hyung Wook Kim, Su Bum Park, Young Mi Hong, Ki Tae Yoon, Mong Cho, Hyung Seok Nam, SM Bakhtiar UI Islam

Clin Mol Hepatol.2016;22(4):466-476. Published online December 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0063

Cited By 2

Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy

Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song

Clin Mol Hepatol.2016;22(3):390-395. Published online August 30, 2016
DOI: https://doi.org/10.3350/cmh.2015.0050

Cited By 1

Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection

Hee Chul Nam, Hae Lim Lee, Hyun Yang, Myeong Jun Song

Clin Mol Hepatol.2016;22(2):259-266. Published online June 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0020

Cited By 5

Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis

Hye Young Jwa, Yoo-Kyung Cho, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong, Bong Soo Kim, Byoung-Wook Lee, Byung-Cheol Song

Clin Mol Hepatol.2016;22(1):183-187. Published online March 28, 2016
DOI: https://doi.org/10.3350/cmh.2016.22.1.183

Cited By 3

Magnetization-tagged MRI is a simple method for predicting liver fibrosis

Kyung-Eun Kim, Mi-Suk Park, Sohae Chung, Chansik An, Leon Axel, Rakhmonova Gulbahor Ergashovna

Clin Mol Hepatol.2016;22(1):140-145. Published online March 28, 2016
DOI: https://doi.org/10.3350/cmh.2016.22.1.140

Erectile dysfunction in patients with liver disease related to chronic hepatitis B

Min Kim, Seul Young Kim, Woo Sun Rou, Se Woong Hwang, Byung Seok Lee

Clin Mol Hepatol.2015;21(4):352-357. Published online December 24, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.4.352

Cited By 8

What we know about paracentesis induced circulatory dysfunction?

Jeong Han Kim

Clin Mol Hepatol.2015;21(4):349-351. Published online December 24, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.4.349

Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis

Jung Wha Chung, Gi Hyun Kim, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Sook-Hyang Jeong, Jin-Wook Kim

Clin Mol Hepatol.2014;20(4):384-391. Published online December 24, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.4.384

Cited By 22

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B

Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong

Clin Mol Hepatol.2014;20(4):347-354. Published online December 24, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.4.347

Cited By 8

The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites

Jun Jae Kim, Jeong Han Kim, Ja Kyung Koo, Yun Jung Choi, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol.2014;20(1):47-55. Published online March 26, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.1.47

Cited By 1

Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data

Hyung Ki Kim, Yoon Jun Kim, Woo Jin Chung, Soon Sun Kim, Jae Jun Shim, Moon Seok Choi, Do Young Kim, Dae Won Jun, Soon Ho Um, Sung Jae Park, Hyun Young Woo, Young Kul Jung, Soon Koo Baik, Moon Young Kim, Soo Young Park, Jae Myeong Lee, Young Seok Kim

Clin Mol Hepatol.2014;20(1):18-27. Published online March 26, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.1.18

Cited By 8

Management of portal hypertensive gastropathy and other bleeding

Woo Jin Chung

Clin Mol Hepatol.2014;20(1):1-5. Published online March 26, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.1.1

Cited By 2

Acute-on-chronic liver failure

Tae Yeob Kim, Dong Joon Kim

Clin Mol Hepatol.2013;19(4):349-359. Published online December 28, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.4.349

Cited By 32

A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease

Heon Ju Lee, Myung Jin Oh

Clin Mol Hepatol.2013;19(2):179-184. Published online June 27, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.2.179

Cited By 4

Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis

Pei Chuan Tsung, Soo Hyung Ryu, In Hye Cha, Hee Won Cho, Jin Nam Kim, You Sun Kim, Jeong Seop Moon

Clin Mol Hepatol.2013;19(2):131-139. Published online June 27, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.2.131

Cited By 19

A case of variceal bleeding from the jejunum in liver cirrhosis

Chan Woong Park, Sae Hee Kim, Hyeon Woong Yang, Yun Jung Lee, Sung Hee Jung, Ho Sup Song, Sang Ok Lee, Anna Kim, Sang Woo Cha

Clin Mol Hepatol.2013;19(1):78-81. Published online March 25, 2013
DOI: https://doi.org/10.3350/cmh.2013.19.1.78

Cited By 2

Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study

Se Young Jang, Go Heun Kim, Soo Young Park, Chang Min Cho, Won Young Tak, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Jae Myeong Lee, Sang Gyune Kim, Dae Yong Kim, Young Seok Kim, Se-Ok Lee, Yang Won Min, Joon Hyeok Lee, Seung Woon Paik, Byung Chul Yoo, Jae Wan Lim, Hong Joo Kim, Yong Kyun Cho, Joo Hyun Sohn, Jae Yoon Jeong, Yu Hwa Lee, Tae Yeob Kim, Young Oh Kweon

Clin Mol Hepatol.2012;18(4):368-374. Published online December 21, 2012
DOI: https://doi.org/10.3350/cmh.2012.18.4.368

Cited By 15

Association between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus

Seun Joo Ahn, Dong Kyu Kim, Soon Sun Kim, Chang Bum Bae, Hyo Jung Cho, Han Gyeol Kim, Young Jip Kim, Joo Ho Lee, Hyo Jin Lee, Mi Yeon Lee, Kee Bum Kim, Jin Hee Cho, Sung Won Cho, Jae Youn Cheong

Clin Mol Hepatol.2012;18(3):295-301. Published online September 25, 2012
DOI: https://doi.org/10.3350/cmh.2012.18.3.295

Cited By 8

Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma

Soon Ha Kwon, Soung Won Jeong, Jae Young Jang, Ji Eun Lee, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, So-Young Jin

Clin Mol Hepatol.2012;18(3):287-294. Published online September 25, 2012
DOI: https://doi.org/10.3350/cmh.2012.18.3.287

Cited By 8

Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience

Eun Ju Cho, Su Hyeon Jeong, Byung Hoon Han, Sang Uk Lee, Byung Chul Yun, Eun Taek Park

Clin Mol Hepatol.2012;18(2):219-224. Published online June 26, 2012
DOI: https://doi.org/10.3350/cmh.2012.18.2.219

Cited By 18

1 | 2 | 3 | 4 |